GAL-1F Blood Glucose Monitoring System, GAL-1F Pro Blood Glucose Monitoring System

Glucose Oxidase, Glucose

Apex BioTechnology Corp.

The following data is part of a premarket notification filed by Apex Biotechnology Corp. with the FDA for Gal-1f Blood Glucose Monitoring System, Gal-1f Pro Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK142689
510k NumberK142689
Device Name:GAL-1F Blood Glucose Monitoring System, GAL-1F Pro Blood Glucose Monitoring System
ClassificationGlucose Oxidase, Glucose
Applicant Apex BioTechnology Corp. No. 7, Li-Hsin Road V, Hsinchu Science Park Hsinchu,  TW 30078
ContactHsue-mei Lee
CorrespondentHsue-mei Lee
Apex BioTechnology Corp. No. 7, Li-Hsin Road V, Hsinchu Science Park Hsinchu,  TW 30078
Product CodeCGA  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-09-22
Decision Date2015-08-06
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.